Ascend Advanced Therapies Limited
Manufacture of pharmaceutical preparations · London
ActiveUnited KingdomIncorporated 2021Private Limited Company
Financial position
Accounts to 2024-12-31 · GBP · Company accounts
Net assets
£51,819,329
Cash
£21,248,607
Turnover
—
Profit / loss
−£22,417,689
Current assets
£28,930,617
Creditors < 1 year
£9,780,754
Equity
£51,819,329
Average employees
16
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2024-12-31Company | 2023-12-31Company | 2023-01-01Company |
|---|---|---|---|
| Balance sheet | |||
| Net assets | £51,819,329 | £41,280,721 | £67,868,234 |
| Equity | £51,819,329 | £41,280,721 | £67,868,234 |
| Assets | |||
| Fixed assets | £34,965,036 | £22,035,622 | — |
| Property, plant & equipment | £529,906 | £746,459 | — |
| Current assets | £28,930,617 | £29,803,518 | — |
| Cash at bank | £21,248,607 | £22,327,706 | — |
| Liabilities | |||
| Creditors within one year | £9,780,754 | £7,558,419 | — |
| Provisions | −£2,295,570 | −£3,000,000 | — |
| Net current assets | £19,149,863 | £22,245,099 | — |
| Assets less current liabilities | £54,114,899 | £44,280,721 | — |
| Profit & loss | |||
| Profit / loss | −£22,417,689 | −£26,587,513 | — |
| People & pay | |||
| Average employees | 16 | 27 | — |
| Source evidence | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
2 outstanding chargesFixed · created 2023-08-21
—
OutstandingFixed · created 2023-08-21
—
Outstanding